PMID: 9160111Jan 1, 1997Paper

Colorectal cancer and nonsteroidal anti-inflammatory drugs

Advances in Pharmacology
W E Smalley, R N DuBois

Abstract

The authors have presented a concise review of the studies which evaluate the risk of colorectal cancer among NSAID users. Animals studies have clearly documented a protective effect of NSAIDs in preventing colon cancers in a carcinogen-induced (AOM) model. NSAIDs are protective in the animal model, even if given 14 weeks after administration of the carcinogen, indicating that they must be playing a role very early in the adenoma-to-carcinoma sequence of events. Several studies have indicated that treatment of FAP patients with NSAIDs causes a regression of adenomas that were already present prior to initiation of NSAID therapy. Many epidemiological studies have examined the relationship between aspirin use and colorectal cancer. Most of these studies have shown a marked decrease in the relative risk (40-50%) of colorectal cancer among continuous aspirin users. The appropriate dose and duration of aspirin treatment for optimal effects are still unknown. Future work, directed at the molecular basis for the chemoprotective effects of NSAIDs in humans, may reveal strategies for the development of better chemopreventive agents. One effect shared by all NSAIDs is their ability to inhibit cyclooxygenase. Presently, it is not clear wh...Continue Reading

Citations

Apr 15, 2020·International Journal of Molecular Sciences·Silvia ZappavignaMichele Caraglia
Jul 27, 2000·Annals of the New York Academy of Sciences·R A Gupta, R N DuBois
Apr 1, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R ZeidlerB Wollenberg
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·Q JiangB N Ames
Sep 12, 2000·Current Gastroenterology Reports·N Arber, R N DuBois
May 12, 2000·Alimentary Pharmacology & Therapeutics·R N Dubois
Nov 18, 2000·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·M Osiri, L W Moreland
Mar 10, 2001·Antioxidants & Redox Signaling·C M PayneH Garewal
Nov 28, 2001·The American Journal of Clinical Nutrition·Q JiangB N Ames
Jan 25, 2002·Annals of the New York Academy of Sciences·A UmarE T Hawk
Jan 14, 2003·Pharmacotherapy·Suphat SubongkotDeborah Drajer
Oct 21, 2003·The Annals of Pharmacotherapy·Jill M Herendeen, Celeste Lindley
Jun 24, 2004·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·G N J TytgatG J Peters
Sep 21, 2004·World Journal of Gastroenterology : WJG·Zhi-Hong ZhangHua-Tian Gan
May 26, 2005·Pharmacological Reviews·Vincenzo MollaceDaniela Salvemini
May 10, 2006·Investigational New Drugs·Nico JanssensTim Perera
Aug 10, 2006·Clinical and Experimental Pharmacology & Physiology·Yiner WangXiangfeng Cong
Sep 15, 2006·Journal of Cellular Physiology·Oliver Jay BroomAnita Sjölander
Jun 1, 2007·Applied Immunohistochemistry & Molecular Morphology : AIMM·Laura MasiAlessandro Franchi
Apr 12, 2013·Mediators of Inflammation·Mau SinhaTej P Singh
Jun 1, 2013·Journal of Cancer Prevention·Hee Seung KimYong Sang Song
Aug 26, 2015·Drug Development Research·Brian S Comer
Dec 2, 2017·International Journal of Molecular Sciences·Marta Prieto-VilaTakahiro Ochiya
Jun 3, 2017·International Journal of Inflammation·Anthony M KyriakopoulosVasilleios Zoumpourlis
Apr 28, 2019·International Journal of Molecular Sciences·Valeria TutinoMaria Notarnicola
Aug 7, 1999·Clinical Reviews in Allergy & Immunology·M Peters-Golden
Dec 1, 1999·British Journal of Pharmacology·J A Mitchell, T D Warner
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·K Müller-DeckerG Fürstenberger
Nov 15, 2000·Critical Reviews in Clinical Laboratory Sciences·E Fosslien
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Lawrence J Marnett, Raymond N DuBois
Nov 30, 2002·Expert Opinion on Investigational Drugs·David G Menter
Oct 7, 2003·Oncogene·Peter Anthony Campochiaro, Sean Francis Hackett
Mar 30, 2001·The Journal of Biological Chemistry·H Fujino, J W Regan
Nov 30, 2006·Journal of Cellular Physiology·Peter A Campochiaro
May 29, 2008·Angiology·Mehmet SahinSaadet Gümüslü
Nov 8, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T A GatcliffeR F Holcombe
Feb 26, 2010·PPAR Research·Eric R WagnerRex C Haydon
Dec 15, 2010·Journal of the Korean Society of Coloproctology·Yoon Dae HanChan Heun Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.